| HUMAN-TRIAL | evidence | A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity | Semaglutide | Weight & fat loss · human-rct · n = 400 | — |
| HUMAN-TRIAL | evidence | Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes | Semaglutide | Glycemic control · human-rct · n = 3297 | — |
| HUMAN-TRIAL | evidence | Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk | Semaglutide | human-observational · n = 887132 | — |
| HUMAN-TRIAL | evidence | A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity | Semaglutide | Weight & fat loss · human-rct · n = 68 | — |
| HUMAN-TRIAL | evidence | Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy Men | Semaglutide | Glycemic control · human-rct · n = 105 | — |
| HUMAN-TRIAL | evidence | Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity | Semaglutide | Weight & fat loss · human-rct · n = 338 | — |
| HUMAN-TRIAL | evidence | Semaglutide Anti-Atherosclerotic Mechanisms of Action Study in Type 2 Diabetes Patients | Rybelsus | human-rct · n = 100 | — |
| HUMAN-TRIAL | evidence | A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese | Semaglutide | Weight & fat loss · human-rct · n = 37 | — |
| HUMAN-TRIAL | evidence | Evaluation of Gastric Content of Volunteers Fasting and Using Semaglutide: an Observational and Cross-sectional Study | Semaglutide | human-observational · n = 30 | — |
| HUMAN-TRIAL | evidence | A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease | Semaglutide | Cognition & memory · human-rct · n = 23 | — |
| HUMAN-TRIAL | evidence | Comparison of Body Composition Changes With Weight Loss Interventions | Semaglutide | Weight & fat loss · human-observational · n = 60 | — |
| HUMAN-TRIAL | evidence | A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) | Semaglutide | Cognition & memory · human-rct · n = 1840 | — |
| HUMAN-TRIAL | evidence | Semaglutide as an Adjunct to Dieting in the Treatment of Type 2 Diabetes | Ozempic | Glycemic control · human-rct · n = 50 | — |
| HUMAN-TRIAL | evidence | Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease | Semaglutide | Cognition & memory · human-rct · n = 30 | — |
| HUMAN-TRIAL | evidence | Prevention of Progression of Prediabetes, Obesity and CV Risk | Rybelsus | human-rct · n = 64 | — |
| HUMAN-TRIAL | evidence | Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea | Ozempic | Glycemic control · human-observational · n = 600 | — |
| HUMAN-TRIAL | evidence | Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes | Semaglutide | Glycemic control · n = 20 | — |
| HUMAN-TRIAL | evidence | A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes | Semaglutide | Glycemic control · human-rct · n = 1441 | — |
| HUMAN-TRIAL | evidence | A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity | Semaglutide | Weight & fat loss · human-rct · n = 120 | — |
| HUMAN-TRIAL | evidence | A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes | Semaglutide | Glycemic control · human-rct · n = 96 | — |
| HUMAN-TRIAL | evidence | A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term | Semaglutide | Weight & fat loss · human-rct · n = 609 | — |
| HUMAN-TRIAL | evidence | Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus | Semaglutide | Glycemic control · human-rct · n = 302 | — |
| HUMAN-TRIAL | evidence | A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different Times | Semaglutide | Glycemic control · human-rct · n = 156 | — |
| HUMAN-TRIAL | evidence | Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study) | Semaglutide | human-rct · n = 142 | — |
| HUMAN-TRIAL | evidence | A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of Semaglutide | Semaglutide | Weight & fat loss · human-rct · n = 28 | — |
| HUMAN-TRIAL | evidence | Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects | Semaglutide | Glycemic control · n = 24 | — |
| HUMAN-TRIAL | evidence | Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM | Semaglutide | human-rct · n = 30 | — |
| HUMAN-TRIAL | evidence | Comparison of Body Weight Change Through Different Smeglutide Administration Methods | Semaglutide | human-rct · n = 80 | — |
| HUMAN-TRIAL | evidence | Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease | Semaglutide | Weight & fat loss · human-rct · n = 48 | — |
| HUMAN-TRIAL | evidence | Safety, Tolerability, and Profile of Action of Drug in the Body of NN9535 in Healthy Male Japanese and Caucasian Subjects | NN9535 | Glycemic control · human-rct · n = 84 | — |
| HUMAN-TRIAL | evidence | Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss | Wegovy | Weight & fat loss · human-rct · n = 200 | — |
| HUMAN-TRIAL | evidence | Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes | Semaglutide | Glycemic control · human-rct · n = 1089 | — |
| HUMAN-TRIAL | evidence | Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc | Semaglutide | Weight & fat loss · human-rct · n = 104 | — |
| HUMAN-TRIAL | evidence | Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes | Semaglutide | Glycemic control · human-rct · n = 154 | — |
| HUMAN-TRIAL | evidence | Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients | Ozempic | Glycemic control · human-rct · n = 52 | — |
| HUMAN-TRIAL | evidence | A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes | Semaglutide | Glycemic control · human-rct · n = 28 | — |
| HUMAN-TRIAL | evidence | The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial | Rybelsus | Glycemic control · human-rct · n = 64 | — |
| HUMAN-TRIAL | evidence | Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity | Semaglutide | Weight & fat loss · human-rct · n = 201 | — |
| HUMAN-TRIAL | evidence | Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes | Semaglutide | Glycemic control · human-rct · n = 577 | — |
| HUMAN-TRIAL | evidence | Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk | Semaglutide | Weight & fat loss · human-observational · n = 120000 | — |
| HUMAN-TRIAL | evidence | A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight | Semaglutide | Weight & fat loss · human-rct · n = 3400 | — |
| HUMAN-TRIAL | evidence | SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes. | Ozempic | Glycemic control · human-rct · n = 240 | — |
| HUMAN-TRIAL | evidence | A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Denmark, as Part of Local Clinical Practice | Semaglutide | Glycemic control · human-observational · n = 99 | — |
| HUMAN-TRIAL | evidence | Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes | Ozempic | Glycemic control · human-rct · n = 60 | — |
| HUMAN-TRIAL | evidence | GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV | Rybelsus | Lipid & cardiovascular markers · human-rct · n = 200 | — |
| HUMAN-TRIAL | evidence | Glutide for Ending Methamphetamine | Semaglutide | Addiction & substance use · human-rct · n = 162 | — |
| HUMAN-TRIAL | evidence | A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause | Semaglutide | Glycemic control · n = 27 | — |
| HUMAN-TRIAL | evidence | A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes | Semaglutide | Glycemic control · human-rct · n = 792 | — |
| HUMAN-TRIAL | evidence | Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3) | Wegovy | human-rct · n = 100 | — |
| HUMAN-TRIAL | evidence | A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet | Semaglutide | Weight & fat loss · human-rct · n = 80 | — |